Everolimus Oral Product ( DrugBank: Everolimus )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
89	リンパ脈管筋腫症	1
158	結節性硬化症	1

89. リンパ脈管筋腫症

臨床試験数 : 38 / 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02061397 (ClinicalTrials.gov)	March 2014	23/1/2014	Safety of Simvastatin in LAM and TSC	The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With T ...	Lymphangioleiomyomatosis;Tuberous Sclerosis Complex	Drug: Simvastatin;Drug: Sirolimus Oral Product;Drug: Everolimus Oral Product	University of Pennsylvania	The LAM Foundation	Completed	18 Years	N/A	Female	10	Phase 1/Phase 2	United States

臨床試験数 : 112 / 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02061397 (ClinicalTrials.gov)	March 2014	23/1/2014	Safety of Simvastatin in LAM and TSC	The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With T ...	Lymphangioleiomyomatosis;Tuberous Sclerosis Complex	Drug: Simvastatin;Drug: Sirolimus Oral Product;Drug: Everolimus Oral Product	University of Pennsylvania	The LAM Foundation	Completed	18 Years	N/A	Female	10	Phase 1/Phase 2	United States